{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:49:00Z","timestamp":1788364140055,"version":"build-2803163510"},"reference-count":19,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Orthopaedic Journal of Sports Medicine"],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The favorable benefit-risk profile of topical nonsteroidal anti-inflammatory drugs (NSAIDs) makes them a preferred treatment for pain relief in soft tissue injuries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To assess the efficacy and safety of a novel etofenamate 70-mg medicated plaster in patients with acute uncomplicated ankle sprain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Randomized controlled trial; Level of evidence, 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients with grade 1 or 2 ankle sprain of recent onset were randomized to etofenamate or placebo plasters (1:1) applied twice daily for 7 days. Clinical assessments, including ankle pain on movement (POM) in mm on a 100-mm visual analog scale (VAS), were made at predefined intervals during the treatment period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 156 male or female adult patients (mean age, 35.3 \u00b1 11.8 years) were enrolled. The fall in VAS values for POM from baseline to 72 hours was markedly in favor of the etofenamate plaster, with respective reductions of 52.7% and 24.0% for active and placebo plasters (least squares mean treatment difference, 22.1 mm; P value for analysis of covariance &lt; .0001). Similar clinically relevant differences between etofenamate and placebo were seen for POM at the 48-, 96-, and 168-hour visits ( P &lt; .0001). These differences between etofenamate and placebo plasters were reflected in area under the curve for POM, pain at rest, and ankle swelling measured at various time points during the 7 days. Time taken to achieve a meaningful (30%) and optimal (50%) reduction of POM was significantly shorter in the etofenamate group. The responder rate (proportion of patients with at least 50% pain reduction at 72 hours) was 52.5% for the etofenamate plaster and 7.7% for the placebo. A significantly greater proportion of patients randomized to etofenamate rated their progress and\/or the treatment as \u201cgood\u201d or \u201cvery good.\u201d The medicated plasters adhered well over the 12-hour dosing period and were very well-tolerated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>With respect to the investigated indication, uncomplicated ankle sprain, the etofenamate plaster has therapeutic efficacy that is similar to that for the best available topical NSAID formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration:<\/jats:title>\n                    <jats:p>2016-000252-99 (EudraCT number).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23259671211032591","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T16:15:55Z","timestamp":1628784955000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Safety of an Etofenamate Medicated Plaster for Acute Ankle Sprain: A Randomized Controlled Trial"],"prefix":"10.1177","volume":"9","author":[{"given":"Hans-Georg","family":"Predel","sequence":"first","affiliation":[{"name":"Institute of Circulatory Research and Sports Medicine, German Sport University Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Leary","sequence":"additional","affiliation":[{"name":"Dr. Regenold, Badenweiler, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Imboden","sequence":"additional","affiliation":[{"name":"Drossapharm, Arlesheim, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bulitta","sequence":"additional","affiliation":[{"name":"CRM Biometrics, Bornheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giannetti","sequence":"additional","affiliation":[{"name":"Clinsearch, Walchwil, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"bibr1-23259671211032591","first-page":"1729","volume":"37","author":"Ascherl R","year":"1982","journal-title":"Fortschr Med"},{"key":"bibr2-23259671211032591","first-page":"72","volume":"2","author":"Billigmann P","year":"1992","journal-title":"Praktische Traumatologie Sportmedizin"},{"key":"bibr3-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1136\/emj.20.6.508"},{"key":"bibr4-23259671211032591","doi-asserted-by":"publisher","DOI":"10.2165\/11585890-000000000-00000"},{"key":"bibr5-23259671211032591","first-page":"CD007402","volume":"6","author":"Derry S","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr6-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1990.tb03443.x"},{"key":"bibr7-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"bibr8-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12219"},{"key":"bibr9-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.1998.tb02667.x"},{"key":"bibr10-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1177\/0363546509338107"},{"key":"bibr11-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1177\/0363546504268135"},{"key":"bibr12-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e318257ed41"},{"key":"bibr13-23259671211032591","volume-title":"KCE Reports 197C","author":"Roosen P","year":"2013"},{"key":"bibr14-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)82656-3"},{"key":"bibr15-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-014-2851-6"},{"key":"bibr16-23259671211032591","doi-asserted-by":"publisher","DOI":"10.1002\/ca.20703"},{"key":"bibr17-23259671211032591","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.01537"},{"issue":"1","key":"bibr18-23259671211032591","first-page":"93","volume":"63","author":"Wolfe MW","year":"2001","journal-title":"Am Fam Physician"},{"key":"bibr19-23259671211032591","unstructured":"Randomized, controlled, double-blind, multicenter trial to evaluate the efficacy and safety of an etofenamate 5% cutaneous patch vs. placebo in the treatment of acute uncomplicated unilateral ankle sprain. EudraCT Identifier: 2014-001720-30. Posted July 16, 2016. Accessed July 30, 2021. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2014-001720-30\/results"}],"container-title":["Orthopaedic Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259671211032591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23259671211032591","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259671211032591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:57:56Z","timestamp":1777593476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23259671211032591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"alternative-id":["10.1177\/23259671211032591"],"URL":"https:\/\/doi.org\/10.1177\/23259671211032591","relation":{},"ISSN":["2325-9671","2325-9671"],"issn-type":[{"value":"2325-9671","type":"print"},{"value":"2325-9671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]},"article-number":"23259671211032591"}}